The downgrade to 1H17 earnings was released to the market on 21 Feb. It was priced into the market then. VRT subsequently recovered significantly with a bullish uptrend to $6.15. Prior to the seasonally weak May/June tax selling season.
IMO this is a decent entry point given tax selling. IVF cycles expected to stabilise. Morgan Stanley had price target of $8.10 recently.
The downgrade to 1H17 earnings was released to the market on 21...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)